Cargando…
The anti-tumoral effects of the oxygen carrier YQ23 in a triple-negative breast cancer syngeneic model
BACKGROUND: Triple-negative breast cancer (TNBC), an aggressive breast cancer subtype, is associated with poor prognosis and high mortality rate. In the search for effective therapeutic options, preclinical studies have suggested using systemic oxygenation to inhibit tumor growth and metastasis in v...
Autores principales: | Chow, Elysian, Lau, Jonathan S. H., Wai, Terence, Lam, Ian P. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798571/ https://www.ncbi.nlm.nih.gov/pubmed/35116399 http://dx.doi.org/10.21037/tcr-20-2768 |
Ejemplares similares
-
A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells
por: Li, Chang Xian, et al.
Publicado: (2014) -
A Novel Cross-Linked Hemoglobin-Based Oxygen Carrier, YQ23, Extended the Golden Hour for Uncontrolled Hemorrhagic Shock in Rats and Miniature Pigs
por: Kuang, Lei, et al.
Publicado: (2021) -
Cytogenetic and Yq microdeletion screening studies in infertile males
por: Suganya, J, et al.
Publicado: (2014) -
A de novo derivative Y chromosome (partial Yq deletion and partial duplication of Yp and Yq) in a female with disorders of sex development
por: Liu, Qing‐Song, et al.
Publicado: (2018) -
Methodological errors in screening of Yq microdeletion in Iranian azoospermic men
por: Saliminejad, Kioomars, et al.
Publicado: (2012)